Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Debt Ratio (2021 - 2025)

Historic Debt Ratio for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to 0.01.

  • Coeptis Therapeutics Holdings' Debt Ratio fell 3684.8% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 3684.8%. This contributed to the annual value of 0.13 for FY2024, which is 30757.19% up from last year.
  • As of Q3 2025, Coeptis Therapeutics Holdings' Debt Ratio stood at 0.01, which was down 3684.8% from 0.01 recorded in Q2 2025.
  • Coeptis Therapeutics Holdings' Debt Ratio's 5-year high stood at 0.24 during Q4 2021, with a 5-year trough of 0.01 in Q2 2022.
  • For the 5-year period, Coeptis Therapeutics Holdings' Debt Ratio averaged around 0.04, with its median value being 0.02 (2023).
  • As far as peak fluctuations go, Coeptis Therapeutics Holdings' Debt Ratio plummeted by 9223.0% in 2022, and later soared by 30757.19% in 2024.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Debt Ratio (Quarter) stood at 0.24 in 2021, then tumbled by 92.23% to 0.02 in 2022, then skyrocketed by 73.17% to 0.03 in 2023, then skyrocketed by 307.57% to 0.13 in 2024, then crashed by 92.09% to 0.01 in 2025.
  • Its Debt Ratio was 0.01 in Q3 2025, compared to 0.01 in Q2 2025 and 0.06 in Q1 2025.